EMERGENT BIOSOLUTIONS
$1,430,164.07 CAD
Originally $649,235 — +120% through amendments What is an amendment?
2 warning signs on this record
-
Only one bid
This contract was open to competition, but only one company made an offer.
Some work is so specialized that few companies can do it.
-
Cost at least doubled
Changes after the signature made this contract cost at least two times its first price, and at least $100,000 more.
Many contracts are made to grow, for example when a department adds more work or uses an option to extend.
A warning sign is a reason to look closer, not proof that someone did something wrong. How the checks work
- Department
- Public Health Agency of Canada
- Program The named fund or plan that the money comes from.
- Pharmaceutical and other medicinal products
- Recipient country
- Canada
- Fiscal year The government's budget year. It starts on April 1 and ends on March 31. For example, 2023-2024 is from April 2023 to March 2024.
- 2026-2027
- Agreement period The start date and the end date of the deal. The money can be paid at different times in this period.
- March 17, 2025 – March 31, 2027
- Competition
- Traditional competitive The government asks companies for offers and selects one of them. In open bidding, any company can make an offer. · 1 bid received
- Reference
- phac-aspc:C-2026-2027-Q1-00341
Published purpose
Pharmaceutical and Other Medicinal Products
Earlier values of this contract
This contract has 1 earlier published value. The newest value replaced it. The amount on this page is the newest value. How we count amended contracts
| Reporting period | Kind | Value |
|---|---|---|
| 2024-2025-Q4 | Contract | $649,235.10 |
| 2026-2027-Q1 | Amendment (newest value) | $1,430,164.07 |
Community tags
Tags are applied by readers, not by this site. One tag per person per record.